Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer
Sublobar resection for early‐stage lung cancer has been used for patients who are not candidates for lobar resection. However, sublobar resection is associated with high local recurrence rates in the context of tumor‐free parenchymal margins. The mechanism underlying this high recurrence rate is not...
Gespeichert in:
Veröffentlicht in: | International journal of cancer 2005-03, Vol.113 (6), p.1022-1025 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1025 |
---|---|
container_issue | 6 |
container_start_page | 1022 |
container_title | International journal of cancer |
container_volume | 113 |
creator | Masasyesva, Brett G. Tong, Betty C. Brock, Malcolm V. Pilkington, Thomas Goldenberg, David Sidransky, David Harden, Susan Westra, William H. Califano, Joseph |
description | Sublobar resection for early‐stage lung cancer has been used for patients who are not candidates for lobar resection. However, sublobar resection is associated with high local recurrence rates in the context of tumor‐free parenchymal margins. The mechanism underlying this high recurrence rate is not well understood. We hypothesized that this elevated risk of local recurrence is due to undetected tumor cells present at parenchymal margins thought to be negative by conventional light microscopy. Thirteen of 44 patients who underwent sublobar resection for lung cancer were found to have a k‐ras mutation at codon 12.1. A novel fluorescence‐based assay for detection of rare copies of mutant DNA in a background of wild‐type DNA, fluorescent gap ligase chain reaction, was used to quantitate the mutant/wild‐type DNA in a range of 1 to 1/10,000 in histologically normal margins from these resections. Nine of 13 patients had at least one margin with the number of mutant cells over or equal to a threshold of 1/5,000, and of these, 6/9 (67%) recurred locally. None of the remaining 4 patients without mutant DNA in any surgical margin had evidence of recurrence. The higher rate of local recurrence associated with sublobar resection of lung cancer is likely due to the occult presence of tumor cells at resection margins. These occult tumor cells can be quantitated using a novel fluorescence‐based assay and define a group of patients at high risk for local recurrence who are candidates for adjuvant therapy or more extensive resection. This methodology may be adaptable to a real‐time format for intraoperative use. © 2004 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/ijc.20683 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67350065</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67350065</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4543-177e40256110a82d1250f5f9f1ced4685a5f37ae011a328ce0428851a4ce3b863</originalsourceid><addsrcrecordid>eNp10E1LwzAYB_AgipvTg19AclHw0O1J0rT1KMOXycSLnjyUNH0yMrJ2Ji2yb2-0g508JZBfnpc_IZcMpgyAz-xaTzlkhTgiYwZ3eQKcyWMyjm-Q5ExkI3IWwhqAMQnpKRkxKeON8TH5fG0d6t4pTzfKr2xDVaPcLthAtx5rq7tAXauVoz4y77HRSJXp0NPQV66t4kePAXVn24a2hrq-WVGtIvPn5MQoF_Bif07Ix-PD-_w5Wb49Leb3y0SnMhUJy3NMgcuMMVAFrxmXYKS5M0xjnWaFVNKIXGGcXgleaISUF4VkKtUoqiITE3Iz1N369qvH0JUbGzQ6pxps-1BmuZAAmYzwdoDatyF4NOXW27j2rmRQ_iZZxiTLvySjvdoX7asN1ge5jy6C6z1QIeZjfNzZhoPLUsk5z6ObDe7bOtz937FcvMyH1j9RXImx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67350065</pqid></control><display><type>article</type><title>Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Masasyesva, Brett G. ; Tong, Betty C. ; Brock, Malcolm V. ; Pilkington, Thomas ; Goldenberg, David ; Sidransky, David ; Harden, Susan ; Westra, William H. ; Califano, Joseph</creator><creatorcontrib>Masasyesva, Brett G. ; Tong, Betty C. ; Brock, Malcolm V. ; Pilkington, Thomas ; Goldenberg, David ; Sidransky, David ; Harden, Susan ; Westra, William H. ; Califano, Joseph</creatorcontrib><description>Sublobar resection for early‐stage lung cancer has been used for patients who are not candidates for lobar resection. However, sublobar resection is associated with high local recurrence rates in the context of tumor‐free parenchymal margins. The mechanism underlying this high recurrence rate is not well understood. We hypothesized that this elevated risk of local recurrence is due to undetected tumor cells present at parenchymal margins thought to be negative by conventional light microscopy. Thirteen of 44 patients who underwent sublobar resection for lung cancer were found to have a k‐ras mutation at codon 12.1. A novel fluorescence‐based assay for detection of rare copies of mutant DNA in a background of wild‐type DNA, fluorescent gap ligase chain reaction, was used to quantitate the mutant/wild‐type DNA in a range of 1 to 1/10,000 in histologically normal margins from these resections. Nine of 13 patients had at least one margin with the number of mutant cells over or equal to a threshold of 1/5,000, and of these, 6/9 (67%) recurred locally. None of the remaining 4 patients without mutant DNA in any surgical margin had evidence of recurrence. The higher rate of local recurrence associated with sublobar resection of lung cancer is likely due to the occult presence of tumor cells at resection margins. These occult tumor cells can be quantitated using a novel fluorescence‐based assay and define a group of patients at high risk for local recurrence who are candidates for adjuvant therapy or more extensive resection. This methodology may be adaptable to a real‐time format for intraoperative use. © 2004 Wiley‐Liss, Inc.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/ijc.20683</identifier><identifier>PMID: 15515012</identifier><identifier>CODEN: IJCNAW</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Biological and medical sciences ; Carcinoma, Non-Small-Cell Lung - genetics ; Carcinoma, Non-Small-Cell Lung - pathology ; Carcinoma, Non-Small-Cell Lung - surgery ; DNA Primers ; gap ligase ; Humans ; k‐ras ; lung cancer ; Lung Neoplasms - genetics ; Lung Neoplasms - pathology ; Lung Neoplasms - surgery ; Medical sciences ; mutation detection ; Neoplasm Recurrence, Local - pathology ; Neoplasm Staging ; Pneumology ; Polymerase Chain Reaction ; Retrospective Studies ; Tumors ; Tumors of the respiratory system and mediastinum</subject><ispartof>International journal of cancer, 2005-03, Vol.113 (6), p.1022-1025</ispartof><rights>Copyright © 2004 Wiley‐Liss, Inc.</rights><rights>2005 INIST-CNRS</rights><rights>(c) 2004 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4543-177e40256110a82d1250f5f9f1ced4685a5f37ae011a328ce0428851a4ce3b863</citedby><cites>FETCH-LOGICAL-c4543-177e40256110a82d1250f5f9f1ced4685a5f37ae011a328ce0428851a4ce3b863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fijc.20683$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fijc.20683$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16452227$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15515012$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Masasyesva, Brett G.</creatorcontrib><creatorcontrib>Tong, Betty C.</creatorcontrib><creatorcontrib>Brock, Malcolm V.</creatorcontrib><creatorcontrib>Pilkington, Thomas</creatorcontrib><creatorcontrib>Goldenberg, David</creatorcontrib><creatorcontrib>Sidransky, David</creatorcontrib><creatorcontrib>Harden, Susan</creatorcontrib><creatorcontrib>Westra, William H.</creatorcontrib><creatorcontrib>Califano, Joseph</creatorcontrib><title>Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Sublobar resection for early‐stage lung cancer has been used for patients who are not candidates for lobar resection. However, sublobar resection is associated with high local recurrence rates in the context of tumor‐free parenchymal margins. The mechanism underlying this high recurrence rate is not well understood. We hypothesized that this elevated risk of local recurrence is due to undetected tumor cells present at parenchymal margins thought to be negative by conventional light microscopy. Thirteen of 44 patients who underwent sublobar resection for lung cancer were found to have a k‐ras mutation at codon 12.1. A novel fluorescence‐based assay for detection of rare copies of mutant DNA in a background of wild‐type DNA, fluorescent gap ligase chain reaction, was used to quantitate the mutant/wild‐type DNA in a range of 1 to 1/10,000 in histologically normal margins from these resections. Nine of 13 patients had at least one margin with the number of mutant cells over or equal to a threshold of 1/5,000, and of these, 6/9 (67%) recurred locally. None of the remaining 4 patients without mutant DNA in any surgical margin had evidence of recurrence. The higher rate of local recurrence associated with sublobar resection of lung cancer is likely due to the occult presence of tumor cells at resection margins. These occult tumor cells can be quantitated using a novel fluorescence‐based assay and define a group of patients at high risk for local recurrence who are candidates for adjuvant therapy or more extensive resection. This methodology may be adaptable to a real‐time format for intraoperative use. © 2004 Wiley‐Liss, Inc.</description><subject>Biological and medical sciences</subject><subject>Carcinoma, Non-Small-Cell Lung - genetics</subject><subject>Carcinoma, Non-Small-Cell Lung - pathology</subject><subject>Carcinoma, Non-Small-Cell Lung - surgery</subject><subject>DNA Primers</subject><subject>gap ligase</subject><subject>Humans</subject><subject>k‐ras</subject><subject>lung cancer</subject><subject>Lung Neoplasms - genetics</subject><subject>Lung Neoplasms - pathology</subject><subject>Lung Neoplasms - surgery</subject><subject>Medical sciences</subject><subject>mutation detection</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Staging</subject><subject>Pneumology</subject><subject>Polymerase Chain Reaction</subject><subject>Retrospective Studies</subject><subject>Tumors</subject><subject>Tumors of the respiratory system and mediastinum</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10E1LwzAYB_AgipvTg19AclHw0O1J0rT1KMOXycSLnjyUNH0yMrJ2Ji2yb2-0g508JZBfnpc_IZcMpgyAz-xaTzlkhTgiYwZ3eQKcyWMyjm-Q5ExkI3IWwhqAMQnpKRkxKeON8TH5fG0d6t4pTzfKr2xDVaPcLthAtx5rq7tAXauVoz4y77HRSJXp0NPQV66t4kePAXVn24a2hrq-WVGtIvPn5MQoF_Bif07Ix-PD-_w5Wb49Leb3y0SnMhUJy3NMgcuMMVAFrxmXYKS5M0xjnWaFVNKIXGGcXgleaISUF4VkKtUoqiITE3Iz1N369qvH0JUbGzQ6pxps-1BmuZAAmYzwdoDatyF4NOXW27j2rmRQ_iZZxiTLvySjvdoX7asN1ge5jy6C6z1QIeZjfNzZhoPLUsk5z6ObDe7bOtz937FcvMyH1j9RXImx</recordid><startdate>20050301</startdate><enddate>20050301</enddate><creator>Masasyesva, Brett G.</creator><creator>Tong, Betty C.</creator><creator>Brock, Malcolm V.</creator><creator>Pilkington, Thomas</creator><creator>Goldenberg, David</creator><creator>Sidransky, David</creator><creator>Harden, Susan</creator><creator>Westra, William H.</creator><creator>Califano, Joseph</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050301</creationdate><title>Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer</title><author>Masasyesva, Brett G. ; Tong, Betty C. ; Brock, Malcolm V. ; Pilkington, Thomas ; Goldenberg, David ; Sidransky, David ; Harden, Susan ; Westra, William H. ; Califano, Joseph</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4543-177e40256110a82d1250f5f9f1ced4685a5f37ae011a328ce0428851a4ce3b863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Biological and medical sciences</topic><topic>Carcinoma, Non-Small-Cell Lung - genetics</topic><topic>Carcinoma, Non-Small-Cell Lung - pathology</topic><topic>Carcinoma, Non-Small-Cell Lung - surgery</topic><topic>DNA Primers</topic><topic>gap ligase</topic><topic>Humans</topic><topic>k‐ras</topic><topic>lung cancer</topic><topic>Lung Neoplasms - genetics</topic><topic>Lung Neoplasms - pathology</topic><topic>Lung Neoplasms - surgery</topic><topic>Medical sciences</topic><topic>mutation detection</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Staging</topic><topic>Pneumology</topic><topic>Polymerase Chain Reaction</topic><topic>Retrospective Studies</topic><topic>Tumors</topic><topic>Tumors of the respiratory system and mediastinum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Masasyesva, Brett G.</creatorcontrib><creatorcontrib>Tong, Betty C.</creatorcontrib><creatorcontrib>Brock, Malcolm V.</creatorcontrib><creatorcontrib>Pilkington, Thomas</creatorcontrib><creatorcontrib>Goldenberg, David</creatorcontrib><creatorcontrib>Sidransky, David</creatorcontrib><creatorcontrib>Harden, Susan</creatorcontrib><creatorcontrib>Westra, William H.</creatorcontrib><creatorcontrib>Califano, Joseph</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Masasyesva, Brett G.</au><au>Tong, Betty C.</au><au>Brock, Malcolm V.</au><au>Pilkington, Thomas</au><au>Goldenberg, David</au><au>Sidransky, David</au><au>Harden, Susan</au><au>Westra, William H.</au><au>Califano, Joseph</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>2005-03-01</date><risdate>2005</risdate><volume>113</volume><issue>6</issue><spage>1022</spage><epage>1025</epage><pages>1022-1025</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><coden>IJCNAW</coden><abstract>Sublobar resection for early‐stage lung cancer has been used for patients who are not candidates for lobar resection. However, sublobar resection is associated with high local recurrence rates in the context of tumor‐free parenchymal margins. The mechanism underlying this high recurrence rate is not well understood. We hypothesized that this elevated risk of local recurrence is due to undetected tumor cells present at parenchymal margins thought to be negative by conventional light microscopy. Thirteen of 44 patients who underwent sublobar resection for lung cancer were found to have a k‐ras mutation at codon 12.1. A novel fluorescence‐based assay for detection of rare copies of mutant DNA in a background of wild‐type DNA, fluorescent gap ligase chain reaction, was used to quantitate the mutant/wild‐type DNA in a range of 1 to 1/10,000 in histologically normal margins from these resections. Nine of 13 patients had at least one margin with the number of mutant cells over or equal to a threshold of 1/5,000, and of these, 6/9 (67%) recurred locally. None of the remaining 4 patients without mutant DNA in any surgical margin had evidence of recurrence. The higher rate of local recurrence associated with sublobar resection of lung cancer is likely due to the occult presence of tumor cells at resection margins. These occult tumor cells can be quantitated using a novel fluorescence‐based assay and define a group of patients at high risk for local recurrence who are candidates for adjuvant therapy or more extensive resection. This methodology may be adaptable to a real‐time format for intraoperative use. © 2004 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>15515012</pmid><doi>10.1002/ijc.20683</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0020-7136 |
ispartof | International journal of cancer, 2005-03, Vol.113 (6), p.1022-1025 |
issn | 0020-7136 1097-0215 |
language | eng |
recordid | cdi_proquest_miscellaneous_67350065 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Biological and medical sciences Carcinoma, Non-Small-Cell Lung - genetics Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - surgery DNA Primers gap ligase Humans k‐ras lung cancer Lung Neoplasms - genetics Lung Neoplasms - pathology Lung Neoplasms - surgery Medical sciences mutation detection Neoplasm Recurrence, Local - pathology Neoplasm Staging Pneumology Polymerase Chain Reaction Retrospective Studies Tumors Tumors of the respiratory system and mediastinum |
title | Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T22%3A42%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20margin%20analysis%20predicts%20local%20recurrence%20after%20sublobar%20resection%20of%20lung%20cancer&rft.jtitle=International%20journal%20of%20cancer&rft.au=Masasyesva,%20Brett%20G.&rft.date=2005-03-01&rft.volume=113&rft.issue=6&rft.spage=1022&rft.epage=1025&rft.pages=1022-1025&rft.issn=0020-7136&rft.eissn=1097-0215&rft.coden=IJCNAW&rft_id=info:doi/10.1002/ijc.20683&rft_dat=%3Cproquest_cross%3E67350065%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67350065&rft_id=info:pmid/15515012&rfr_iscdi=true |